Post Archive by Month

When the World Health Organization (WHO) recently announced its recommendations for updating COVID-19 vaccines, many scientists focused on the continued evolution of the SARS-CoV-2 coronavirus and its potential impact on vaccine efficacy. 
Since late 2019, several virus variants have been detected since the initial identification.

New research published by investigators at Massachusetts General Hospital (MGH) shows that the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine, originally developed to prevent tuberculosis, protects individuals with type 1 diabetes from infectious diseases.

Gavi, the Vaccine Alliance today announced that certain countries it supports can now apply to introduce four additional vaccines: preventive Ebola, human rabies vaccine for post-exposure prophylaxis, multivalent meningococcal conjugate, and hepatitis B birth dose.
These four vaccine programs were previously approved by the Gavi Board but were put on hold due to the recent pandemic.
The latest expansion of Gavi's vaccine portfolio aligns with its commitment to ensuring that lower-income countries access impactful vaccines as soon as possible.

While the U.S. economy continues to expand, the health industry is forecasted to exceed the growth in gross domestic product (GDP).
During the entire projection period (2023–32), growth in national health expenditures is projected to average 5.6% and outpace the nominal GDP growth rate of 4.3%.
The estimated amount spent on hospital care, clinical services, drugs (including vaccines), and other health services in 2023 reached an all-time high of $4.1 trillion.

National health expenditures projected to have increased 7.5 percent in 2023, when COVID-19 public health emergency ended

The Ministry of Public Health of the Republic of Cuba recently reported Oropouche virus disease outbreaks in two provinces.
In late May 2024, the Ministry of Public Health reported 74 Oropouche cases from the Provinces of Santiago de Cuba (n=54) and Cienfuegos (n=20).